[A Case of Hormone Receptor-Positive, HER2-Negative Metastatic Recurrent Breast Cancer Successfully Treated with Capivasertib and Fulvestrant in Late-Line Therapy]
{{output}}
A 60-year-old woman who underwent mastectomy for right breast cancer 21 years ago was treated with endocrine therapy, chemotherapy and radiation therapy over a 13-year period following recurrence involving distant lymph nodes, bone, and lung metastases. She al... ...
